The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Respiratory Disease Testing Market Evolve From 2026 To 2030?
The respiratory disease testing market has seen significant expansion in recent years. It is anticipated to increase from $3.74 billion in 2025 to $3.94 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.3%. This historical growth can be attributed to several factors including a higher incidence of chronic respiratory diseases, improvements in hospital diagnostic capabilities, greater awareness regarding early disease detection, the implementation of spirometry testing, and expanded healthcare screening initiatives.
The market size for respiratory disease testing is projected to experience robust expansion in the upcoming years. This market is anticipated to reach a valuation of $4.93 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.8%. Key drivers for this growth during the forecast period include a heightened need for swift and precise respiratory diagnostic tools, increased capital deployment in diagnostic infrastructure, the expansion of at-home respiratory testing options, the escalating integration of AI-powered diagnostic solutions, and a stronger emphasis on population health management. Prominent trends expected within the forecast timeframe involve the greater acceptance of early diagnostic testing methods, an uptick in the utilization of in-vitro diagnostic respiratory tests, the expanding integration of digital pulmonary monitoring devices, the proliferation of point-of-care respiratory testing, and an elevated commitment to preventive respiratory care.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10304&type=smp
What Drivers Are Influencing The Respiratory Disease Testing Market?
An increasing incidence of respiratory ailments is expected to propel the respiratory disease testing market in the future. These conditions encompass medical issues impacting the respiratory system, involving organs like the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. The primary function of respiratory disease testing is the prompt identification and diagnosis of such conditions, facilitating earlier therapeutic interventions and management. Such testing aids in preventing disease advancement and plays a crucial role in curbing the dissemination of contagious respiratory illnesses while mitigating complication risks. As an illustration, data from June 2025 by the Office for Health Improvement and Disparities (OHID), a UK-based government department, indicated a 7% rise in emergency admissions for respiratory disease in England between the financial year ending 2023 and the financial year ending 2024. Consequently, the growing prevalence of respiratory diseases is a significant driver for the respiratory disease testing market.
Which Segment Areas Are Covered In The Respiratory Disease Testing Market Analysis?
The respiratory disease testing market covered in this report is segmented –
1) By Test Type: Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests
2) By Products: Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Products
3) By Application: Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, Other Applications
4) By End-User: Hospitals, Physician clinics, Clinical laboratories, Other End-Users
Subsegments:
1) By Imaging Tests: X-rays, Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans
2) By Mechanical Tests: Spirometry, Peak Flow Measurement, Lung Volume Measurement, Diffusion Capacity Tests
3) By In-Vitro Diagnostic Tests: PCR Tests, Antigen Tests, Antibody Tests, Culture Tests
Which Trends Are Impacting The Growth Of The Respiratory Disease Testing Market?
Leading firms within the respiratory disease testing sector are concentrating on creating sophisticated offerings, including pulmonary function testing, to achieve a competitive advantage. These tests, known as pulmonary function tests, evaluate lung performance and an individual’s respiratory capacity. For instance, Vitalograph Ltd., a UK-based supplier of respiratory diagnostic tools, introduced VitaloPFT in March 2023. The VitaloPFT Series provides sophisticated respiratory diagnostic capabilities through various comprehensive pulmonary function testing choices. This product offers an economical solution for healthcare providers seeking advanced respiratory diagnostics, empowering them to deliver superior patient care. Its design incorporates an intuitive interface and user-friendly features, streamlining the PFT procedure for medical professionals, thus making it straightforward to operate and navigate.
Which Global Companies Are Actively Competing In The Respiratory Disease Testing Market?
Major companies operating in the respiratory disease testing market are Medtronic plc, Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Masimo Corporation, Hamilton Medical AG, Drägerwerk AG & Co. KGaA, Schiller AG, Nonin Medical Inc.
Read the full respiratory disease testing market report here:
https://www.thebusinessresearchcompany.com/report/respiratory-disease-testing-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Respiratory Disease Testing Market?
North America was the largest region in the respiratory disease testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the global respiratory disease testing market during the forecast period. The regions covered in the respiratory disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Respiratory Disease Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10304&type=smp
Browse Through More Reports Similar to the Global Respiratory Disease Testing Market 2026, By The Business Research Company
Vertebroplasty Needles Global Market Report
https://www.thebusinessresearchcompany.com/report/vertebroplasty-needles-global-market-report
Biopsy Devices Global Market Report
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Bioresorbable Medical Material Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model